Market Research Logo

CSL Ltd - Product Pipeline Review - 2016

CSL Ltd - Product Pipeline Review - 2016

Summary

Global Markets Direct’s, ‘CSL Ltd - Product Pipeline Review - 2016’, provides an overview of the CSL Ltd’s pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by CSL Ltd, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

  • The report provides a snapshot of the pipeline therapeutic landscape of CSL Ltd
  • The report provides overview of CSL Ltd including its business description, key facts, and locations and subsidiaries
  • The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
  • The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
  • The report assesses CSL Ltd’s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
  • The report features CSL Ltd’s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects
Reasons to buy
  • Evaluate CSL Ltd’s strategic position with total access to detailed information on its product pipeline
  • Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of therapeutics under development for CSL Ltd
  • Identify potential new clients or partners in the target demographic
  • Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics
  • Devise corrective measures for pipeline projects by understanding CSL Ltd’s pipeline depth and focus of pipeline therapeutics
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope


CSL Ltd Snapshot
CSL Ltd Overview
Key Facts
CSL Ltd - Research and Development Overview
Key Therapeutic Areas
CSL Ltd - Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products - Monotherapy
Pipeline Products - Combination Treatment Modalities
Pipeline Products - Partnered Products
Partnered Products/Combination Treatment Modalities
Pipeline Products - Out-Licensed Products
Out-Licensed Products/Combination Treatment Modalities
CSL Ltd - Pipeline Products Glance
CSL Ltd - Late Stage Pipeline Products
Pre-Registration Products/Combination Treatment Modalities
Phase III Products/Combination Treatment Modalities
CSL Ltd - Clinical Stage Pipeline Products
Phase II Products/Combination Treatment Modalities
Phase I Products/Combination Treatment Modalities
CSL Ltd - Early Stage Pipeline Products
Preclinical Products/Combination Treatment Modalities
Discovery Products/Combination Treatment Modalities
CSL Ltd - Drug Profiles
(coagulation factor II (human) + coagulation factor VII (human) + coagulation factor IX (human) + coagulation factor X (human) + protein C (human) + protein S (human)) - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Antibodies for Undisclosed Indication - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
antihemophilic factor (recombinant), single chain - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
C1 esterase inhibitor (human) - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
CSL-112 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
CSL-311 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
CSL-312 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
CSL-324 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
CSL-346 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
CSL-626 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
CSL-640 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
CSL-650 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
CSL-689 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
CSL-777 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
factor XIII (human) - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
fibrinogen (human) - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
haptoglobin + hemopexin - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
immune globulin (human) - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Monoclonal Antibodies for Undisclosed Indication - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
PODCRC-OHS - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Recombinant Protein for Bleeding and Clotting Disorders - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Recombinant Protein for Hemophilia - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
CSL Ltd - Pipeline Analysis
CSL Ltd - Pipeline Products by Target
CSL Ltd - Pipeline Products by Route of Administration
CSL Ltd - Pipeline Products by Molecule Type
CSL Ltd - Pipeline Products by Mechanism of Action
CSL Ltd - Dormant Projects
CSL Ltd - Company Statement
CSL Ltd - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer
List of Tables
CSL Ltd, Key Facts
CSL Ltd - Pipeline by Indication, 2016
CSL Ltd - Pipeline by Stage of Development, 2016
CSL Ltd - Monotherapy Products in Pipeline, 2016
CSL Ltd - Combination Treatment Modalities in Pipeline, 2016
CSL Ltd - Partnered Products in Pipeline, 2016
CSL Ltd - Partnered Products/ Combination Treatment Modalities, 2016
CSL Ltd - Out-Licensed Products in Pipeline, 2016
CSL Ltd - Out-Licensed Products/ Combination Treatment Modalities, 2016
CSL Ltd - Pre-Registration, 2016
CSL Ltd - Phase III, 2016
CSL Ltd - Phase II, 2016
CSL Ltd - Phase I, 2016
CSL Ltd - Preclinical, 2016
CSL Ltd - Discovery, 2016
CSL Ltd - Pipeline by Target, 2016
CSL Ltd - Pipeline by Route of Administration, 2016
CSL Ltd - Pipeline by Molecule Type, 2016
CSL Ltd - Pipeline Products by Mechanism of Action, 2016
CSL Ltd - Dormant Developmental Projects,2016
CSL Ltd, Other Locations
CSL Ltd, Subsidiaries
List of Figures
CSL Ltd - Pipeline by Top 10 Indication, 2016
CSL Ltd - Pipeline by Stage of Development, 2016
CSL Ltd - Monotherapy Products in Pipeline, 2016
CSL Ltd - Combination Treatment Modalities in Pipeline, 2016
CSL Ltd - Out-Licensed Products in Pipeline, 2016
CSL Ltd - Pipeline by Top 10 Target, 2016
CSL Ltd - Pipeline by Route of Administration, 2016
CSL Ltd - Pipeline by Molecule Type, 2016
CSL Ltd - Pipeline Products by Top 10 Mechanism of Action, 2016

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report